ENRICH Forum: Ethical and Regulatory Issues in Cancer Research: Secondary Research with Biological Samples and Data Under the Revised Common Rule
On Tuesday, September 24, Dr. Yvonne Lau will present about recent regulatory revisions to the Common Rule, 45 CFR part 46, concerning secondary research uses of biological samples and associated data. During the presentation, Dr. Lau will discuss the new provisions pertaining to the protection of identifiable information and identifiable biospecimens including:
- the mandated periodic review by federal agencies of technologies that generate identifiable data
- new exemption for information that is regulated under the HIPAA Privacy Rule
This event sponsored by NCI's Division of Cancer Control and Population Sciences' (DCCPS) Epidemiology and Genomics Research Program and NCI's Division of Cancer Treatment and Diagnosis' (DCTD) Cancer Diagnosis Program.
For more event information please contact Carol Weil at 240-276-5975 or Charlisse Caga-anan at 240-276-6738.
Dr. Yvonne Lau is the Director of the Division of Education and Development HHS' Office for Human Research Protections.
- The Cancer Genomics Cloud: A Secure and Scalable Cloud-Based Platform to Access, Share, and Analyze Multi-Omics Data SetsJanuary 27, 2021Supporting Innovative Cancer Research Through Data PrivacyJanuary 28, 2021Sequence-Structure-Function Modeling for the 3D GenomeJanuary 28, 2021Envisioning the Future of Radiation Oncology Workshop KickoffJanuary 29, 2021